Includes whereas clauses.
Amends GS 90-81.82, concerning informed consent to abortion under the Woman's Right to Know Act, to require the following additional information be provided to a woman before a medical abortion. Requires that, immediately prior to administering the drug Mifepristone, the physician or qualified health professional must inform the woman that both (1) it is possible to discontinue a drug-induced abortion by not taking the Mifepristone and taking progesterone to reverse the effects of the Mifespristone and (2) information on how, where, and from whom women can obtain assistance in discontinuing a medical abortion is available on the Department of Health and Human Services' website. Further, immediately prior to administering the drug Misoprostol, requires the physician or qualified professional to provide medical proof to the woman that fetal death has occurred. Amends GS 90-21.84 to require DHHS to include the above information relating to the drug Mifepristone, as required in new GS 90-21.82(2a)a, on its website. Effective October 1, 2019.
Directs DHHS to update its website to provide information on how, where, and from whom women can obtain assistance in discontinuing the drug-induced abortion process on or before July 1, 2019.
Bill H 22 (2019-2020)Summary date: Feb 5 2019 - More information
© 2021 School of Government The University of North Carolina at Chapel Hill
This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.